Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Recruiting · NCT07819435 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2/3 Efficacy and Safety of PP405 in Adult Males | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Recruiting | Phase 2 / Phase 3 | 2026-10-07 | NCT07819435 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pelage Pharmaceuticals, Inc. | 1 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.